<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">cardiotomsk</journal-id><journal-title-group><journal-title xml:lang="ru">Сибирский журнал клинической и экспериментальной медицины</journal-title><trans-title-group xml:lang="en"><trans-title>Siberian Journal of Clinical and Experimental Medicine</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2713-2927</issn><issn pub-type="epub">2713-265X</issn><publisher><publisher-name>TSU publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.29001/2073-8552-2023-38-2-147-155</article-id><article-id custom-type="elpub" pub-id-type="custom">cardiotomsk-1799</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКИЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL STUDIES</subject></subj-group></article-categories><title-group><article-title>Патогенетическая значимость полиморфных вариантов гена TREM-1 в развитии полиорганной недостаточности после кардиохирургического вмешательства</article-title><trans-title-group xml:lang="en"><trans-title>Pathogenetic significance of polymorphic variants in the TREM-1 gene in the multiple organ failure risk after cardiac surgery</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9714-4080</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Хуторная</surname><given-names>М. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Khutornaya</surname><given-names>M. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Хуторная Мария Владимировна - младший научный сотрудник, лаборатория геномной медицины, отдел экспериментальной медицины</p><p>650002, Российская Федерация, Кемерово, Сосновый бульвар, 6 </p></bio><bio xml:lang="en"><p>Mariya V. Khutornaya - Junior Research Scientist, Laboratory of Genomic Medicine, Department of Experimental Medicine</p><p> 6, Sosnovy blvd., Kemerovo, 650002, Russian Federation </p></bio><email xlink:type="simple">masha_hut@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4467-8732</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Синицкая</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Sinitskaya</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Синицкая Анна Викторовна - канд. биол. наук, научный сотрудник, лаборатория геномной медицины, отдел экспериментальной медицины</p><p> 650002, Российская Федерация, Кемерово, Сосновый бульвар, 6 </p></bio><bio xml:lang="en"><p> Anna V. Sinitskaya - Research Scientist, Laboratory of Genomic Medicine, Department of Experimental Medicine</p><p> 6, Sosnovy blvd., Kemerovo, 650002, Russian Federation </p></bio><email xlink:type="simple">cepoav1991@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4824-2418</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Синицкий</surname><given-names>М. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Sinitsky</surname><given-names>M. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Синицкий Максим Юрьевич - канд. биол. наук, старший научный сотрудник, лаборатория геномной медицины, отдел экспериментальной медицины</p><p>650002, Российская Федерация, Кемерово, Сосновый бульвар, 6 </p></bio><bio xml:lang="en"><p>Maxim Yu. Sinitsk - Cand. Sci. (Biol.), Senior Research Scientist, Laboratory of Genomic Medicine, Department of Experimental Medicine </p><p> 6, Sosnovy blvd., Kemerovo, 650002, Russian Federation </p></bio><email xlink:type="simple">sinitsky.maxim@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3002-2863</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Понасенко</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Ponasenko</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Понасенко Анастасия Валериевна - канд. мед. наук, заведующий лабораторией геномной медицины, отдел экспериментальной медицины</p><p> 650002, Российская Федерация, Кемерово, Сосновый бульвар, 6 </p></bio><bio xml:lang="en"><p>Anastasia V. Ponasenko - Cand. Sci. (Med.), Head of Laboratory of Genomic Medicine, Department of Experimental Medicine </p><p> 6, Sosnovy blvd., Kemerovo, 650002, Russian Federation </p></bio><email xlink:type="simple">ponaav@kemcardio.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8370-3083</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Григорьев</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Grigoriev</surname><given-names>E. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Григорьев Евгений Валерьевич - д-р мед. наук, профессор РАН, заместитель директора по научной и лечебной работе</p><p> 650002, Российская Федерация, Кемерово, Сосновый бульвар, 6 </p></bio><bio xml:lang="en"><p>Evgeniy V. Grigoriev - Dr. Sci. (Med.), Deputy Director for Scientific and Medical Work </p><p> 6, Sosnovy blvd., Kemerovo, 650002, Russian Federation </p></bio><email xlink:type="simple">grigev@kemcardio.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Научно-исследовательский институт комплексных проблем сердечно-сосудистых заболеваний</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Federal State Budgetary Scientific Institution Research Institute for Complex Issues of Cardiovascular Diseases</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>07</day><month>07</month><year>2023</year></pub-date><volume>38</volume><issue>2</issue><fpage>147</fpage><lpage>155</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Хуторная М.В., Синицкая А.В., Синицкий М.Ю., Понасенко А.В., Григорьев Е.В., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Хуторная М.В., Синицкая А.В., Синицкий М.Ю., Понасенко А.В., Григорьев Е.В.</copyright-holder><copyright-holder xml:lang="en">Khutornaya M.V., Sinitskaya A.V., Sinitsky M.Y., Ponasenko A.V., Grigoriev E.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.sibjcem.ru/jour/article/view/1799">https://www.sibjcem.ru/jour/article/view/1799</self-uri><abstract><p>Введение. На сегодняшний день существует потребность в поиске высокоспецифичного, высокочувствительного и простого в использовании маркера полиорганной недостаточности (ПОН), который поможет облегчить ранний прогноз данного неблагоприятного состояния, предотвратить осложнения и снизить смертность в раннем послеоперационном периоде.Цель: оценить патогенетическую значимость полиморфных вариантов гена TREM-1 в развитии ПОН у пациентов с ишемической болезнью сердца (ИБС) после кардиохирургического вмешательства.Материал и методы. Для проведения исследования отобраны 592 пациента с ИБС (564 пациента с неосложненным послеоперационным периодом и 28 пациентов с развившейся ПОН). Проведено генотипирование восьми полиморфных вариантов TREM-1 (rs1817537, rs3804277, rs6910730, rs7768162, rs2234246, rs4711668, rs9471535, rs2234237) методом полимеразной цепной реакции.Результаты. Выявлено, что с повышенным риском развития ПОН после планового оперативного вмешательства ассоциированы аллели Т rs2234246, G rs1817537 и Т rs3804277 TREM-1 по доминантной модели наследования. Со сниженным риском развития ПОН обнаружены ассоциации по двум полиморфным локусам TREM-1 rs7768162 и rs4711668 по аддитивной модели наследования. При изучении полиморфных вариантов rs2234237, rs6910730 и rs9471535 в отношении развития ПОН значимых отличий не выявлено. В исследовании не установлены статистически значимые связи между наследуемым гаплотипом и риском развития ПОН. При помощи программы MDR определены 3 наиболее значимые модели ген-генных взаимодействий полиморфных локусов TREM-1, ассоциированных с развитием ПОН у пациентов после кардиохирургического вмешательства.Заключение. Полученные результаты демонстрируют значимый вклад полиморфных вариантов гена TREM-1 в развитие ПОН у пациентов кардиохирургического профиля.</p></abstract><trans-abstract xml:lang="en"><p>Introduction. Searching of highly specific, sensitive and easy-to-use markers of multiple organ failure (MOF) that will help to the early prognosis of this unfavorable condition, prevent complications and reduce mortality in the early postoperative period is very urgent for the modern medicine.Aim: To study the pathogenetic significance of the TREM-1 gene polymorphism in MOF in patients with coronary artery disease (CAD) in the early postoperative period.Material and methods. 592 CAD patients (564 patients with uncomplicated postoperative period and 28 MOF patients) were selected for the presented study. Genotyping polymorphic variants rs1817537, rs3804277, rs6910730, rs7768162, rs2234246, rs4711668, rs9471535 and rs2234237 in the TREM-1 gene was carried out by polymerase chain reaction.Results. It was found that the allele T (rs2234246), the allele G (rs1817537) and the allele T (rs3804277) in the TREM-1 gene were associated with an increased MOF risk after elective surgery according to the dominant inheritance model. TREM-1 polymorphic loci rs7768162 and rs4711668 were associated with a decreased MOF risk according to the additive inheritance model. We found no significant associations between polymorphic variants rs2234237, rs6910730, rs9471535, as well as inherited haplotype and MOF risk. Using the MDR analysis, three most significant models of gene-gene interactions of TREM-1 polymorphic loci associated with MOF risk in patients after cardiac surgery were identified.Conclusion. The obtained results demonstrate a significant contribution of polymorphic variants in the TREM-1 gene to the development of MOF in patients undergoing cardiac surgery.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>ишемическая болезнь сердца</kwd><kwd>коронарное шунтирование</kwd><kwd>полиорганная недостаточность</kwd><kwd>врожденный иммунитет</kwd><kwd>TREM-1</kwd></kwd-group><kwd-group xml:lang="en"><kwd>coronary artery disease</kwd><kwd>coronary artery bypass surgery</kwd><kwd>multiple organ failure</kwd><kwd>innate immunity</kwd><kwd>TREM-1</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Исследование выполнено при поддержке комплексной программы фундаментальных научных исследований СО РАН в рамках фундаментальной темы НИИ КПССЗ № 0419- 2022-0001</funding-statement><funding-statement xml:lang="en">This study was supported by the Complex Program of Fundamental Research of the Siberian Branch of the Russian Academy of Sciences within the framework of the fundamental research project of Research Institute for Complex Issues of Cardiovascular Diseases No. 0419-2022- 0001.</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Xu F., Li W., Zhang C., Cao R. Performance of sequential organ failure assessment and simplified acute physiology score II for post-cardiac surgery patients in intensive care unit. Front. Cardiovasc. Med. 2021;8:774935. DOI: 10.3389/fcvm.2021.774935.</mixed-citation><mixed-citation xml:lang="en">Xu F., Li W., Zhang C., Cao R. Performance of sequential organ failure assessment and simplified acute physiology score II for post-cardiac surgery patients in intensive care unit. Front. Cardiovasc. Med. 2021;8:774935. DOI: 10.3389/fcvm.2021.774935.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Gourd N.M., Nikitas N. Multiple organ dysfunction syndrome. J. Intensive Care Med. 2020;35(12):1564–1575. DOI: 10.1177/0885066619871452.</mixed-citation><mixed-citation xml:lang="en">Gourd N.M., Nikitas N. Multiple organ dysfunction syndrome. J. Intensive Care Med. 2020;35(12):1564–1575. DOI: 10.1177/0885066619871452.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Hatakeyama N., Matsuda N. Alert cell strategy: mechanisms of inflammatory response and organ protection. Curr. Pharm. Des. 2014;20(36):5766–5778. DOI: 10.2174/138161282036140912122809.</mixed-citation><mixed-citation xml:lang="en">Hatakeyama N., Matsuda N. Alert cell strategy: mechanisms of inflammatory response and organ protection. Curr. Pharm. Des. 2014;20(36):5766–5778. DOI: 10.2174/138161282036140912122809.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Corral-Velez V., Lopez-Delgado J.C., Betancur-Zambrano N.L., Lopez-Suñe N., Rojas-Lora M., Torrado H. et al. The inflammatory response in cardiac surgery: an overview of the pathophysiology and clinical implications. Inflamm. Allergy Drug. Targets. 2015;13(6):367–370. DOI: 10.2174/1871528114666150529120801.</mixed-citation><mixed-citation xml:lang="en">Corral-Velez V., Lopez-Delgado J.C., Betancur-Zambrano N.L., Lopez-Suñe N., Rojas-Lora M., Torrado H. et al. The inflammatory response in cardiac surgery: an overview of the pathophysiology and clinical implications. Inflamm. Allergy Drug. Targets. 2015;13(6):367–370. DOI: 10.2174/1871528114666150529120801.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Gao S., Yi Y., Xia G., Yu C., Ye C., Tu F. et al. The characteristics and pivotal roles of triggering receptor expressed on myeloid cells-1 in autoimmune diseases. Autoimmun. Rev. 2019;18(1):25–35. DOI: 10.1016/j.autrev.2018.07.008.</mixed-citation><mixed-citation xml:lang="en">Gao S., Yi Y., Xia G., Yu C., Ye C., Tu F. et al. The characteristics and pivotal roles of triggering receptor expressed on myeloid cells-1 in autoimmune diseases. Autoimmun. Rev. 2019;18(1):25–35. DOI: 10.1016/j.autrev.2018.07.008.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">de Oliveira Matos A., Dos Santos Dantas P.H., Figueira Marques Silva-Sales M., Sales-Campos H. The role of the triggering receptor expressed on myeloid cells-1 (TREM-1) in non-bacterial infections. Crit. Rev. Microbiol. 2020;46(3):237–252. DOI: 10.1080/1040841X.2020.1751060.</mixed-citation><mixed-citation xml:lang="en">de Oliveira Matos A., Dos Santos Dantas P.H., Figueira Marques Silva-Sales M., Sales-Campos H. The role of the triggering receptor expressed on myeloid cells-1 (TREM-1) in non-bacterial infections. Crit. Rev. Microbiol. 2020;46(3):237–252. DOI: 10.1080/1040841X.2020.1751060.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Scott M.C. Defining and diagnosing sepsis. Emerg. Med. Clin. North Am. 2017;35(1):1–9. DOI: 10.1016/j.emc.2016.08.002.</mixed-citation><mixed-citation xml:lang="en">Scott M.C. Defining and diagnosing sepsis. Emerg. Med. Clin. North Am. 2017;35(1):1–9. DOI: 10.1016/j.emc.2016.08.002.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Vincent J.L., Moreno R., Takala J., Willatts S., De Mendonça A., Bruining H. et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996;22(7):707–710. DOI: 10.1007/BF01709751.</mixed-citation><mixed-citation xml:lang="en">Vincent J.L., Moreno R., Takala J., Willatts S., De Mendonça A., Bruining H. et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996;22(7):707–710. DOI: 10.1007/BF01709751.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Golovkin A.S., Ponasenko A.V., Khutornaya M.V., Kutikhin A.G., Salakhov R.R., Yuzhalin A.E. et al. Association of TLR and TREM-1 gene polymorphisms with risk of coronary artery disease in a Russian population. Gene. 2014;550(1):101–109. DOI: 10.1016/j.gene.2014.08.022.</mixed-citation><mixed-citation xml:lang="en">Golovkin A.S., Ponasenko A.V., Khutornaya M.V., Kutikhin A.G., Salakhov R.R., Yuzhalin A.E. et al. Association of TLR and TREM-1 gene polymorphisms with risk of coronary artery disease in a Russian population. Gene. 2014;550(1):101–109. DOI: 10.1016/j.gene.2014.08.022.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Gourd N.M., Nikitas N. Multiple Organ Dysfunction Syndrome. J. Intensive Care Med. 2020;35(12):1564–1575. DOI: 10.1177/0885066619871452.</mixed-citation><mixed-citation xml:lang="en">Gourd N.M., Nikitas N. Multiple Organ Dysfunction Syndrome. J. Intensive Care Med. 2020;35(12):1564–1575. DOI: 10.1177/0885066619871452.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Bouchon A., Dietrich J., Colonna M. Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J. Immunol. 2000;164(10):4991–4995. DOI: 10.4049/jimmunol.164.10.4991.</mixed-citation><mixed-citation xml:lang="en">Bouchon A., Dietrich J., Colonna M. Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J. Immunol. 2000;164(10):4991–4995. DOI: 10.4049/jimmunol.164.10.4991.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Kuai J., Gregory B., Hill A., Pittman D.D., Feldman J.L., Brown T. et al. TREM-1 expression is increased in the synovium of rheumatoid arthritis patients and induces the expression of pro-inflammatory cytokines. Rheumatology (Oxford). 2009;48(11):1352–1358. DOI: 10.1093/rheumatology/kep235.</mixed-citation><mixed-citation xml:lang="en">Kuai J., Gregory B., Hill A., Pittman D.D., Feldman J.L., Brown T. et al. TREM-1 expression is increased in the synovium of rheumatoid arthritis patients and induces the expression of pro-inflammatory cytokines. Rheumatology (Oxford). 2009;48(11):1352–1358. DOI: 10.1093/rheumatology/kep235.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Joffre J., Potteaux S., Zeboudj L., Loyer X., Boufenzer A., Laurans L. et al. Genetic and pharmacological inhibition of TREM-1 limits the development of experimental atherosclerosis. J. Am. Coll. Cardiol. 2016;68(25):2776–2793. DOI: 10.1016/j.jacc.2016.10.015.</mixed-citation><mixed-citation xml:lang="en">Joffre J., Potteaux S., Zeboudj L., Loyer X., Boufenzer A., Laurans L. et al. Genetic and pharmacological inhibition of TREM-1 limits the development of experimental atherosclerosis. J. Am. Coll. Cardiol. 2016;68(25):2776–2793. DOI: 10.1016/j.jacc.2016.10.015.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Jérémie L., Amir B., Marc D., Sébastien G. The triggering receptor expressed on myeloid cells-1: A new player during acute myocardial infarction. Pharmacol. Res. 2015;100:261–265. DOI: 10.1016/j.phrs.2015.07.027.</mixed-citation><mixed-citation xml:lang="en">Jérémie L., Amir B., Marc D., Sébastien G. The triggering receptor expressed on myeloid cells-1: A new player during acute myocardial infarction. Pharmacol. Res. 2015;100:261–265. DOI: 10.1016/j.phrs.2015.07.027.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Dopheide J.F., Doppler C., Scheer M., Obst V., Radmacher M.C., Radsak M.P. et al. Critical limb ischaemia is characterised by an increased production of whole blood reactive oxygen species and expression of TREM-1 on neutrophils. Atherosclerosis. 2013;229(2):396–403. DOI: 10.1016/j.atherosclerosis.2013.05.029.</mixed-citation><mixed-citation xml:lang="en">Dopheide J.F., Doppler C., Scheer M., Obst V., Radmacher M.C., Radsak M.P. et al. Critical limb ischaemia is characterised by an increased production of whole blood reactive oxygen species and expression of TREM-1 on neutrophils. Atherosclerosis. 2013;229(2):396–403. DOI: 10.1016/j.atherosclerosis.2013.05.029.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Jung E.S., Kim S.W., Moon C.M., Shin D.J., Son N.H., Kim E.S. et al. Relationships between genetic polymorphisms of triggering receptor expressed on myeloid cells-1 and inflammatory bowel diseases in the Korean population. Life Sci. 2011;89(9–10):289–294. DOI: 10.1016/j.lfs.2011.06.018.</mixed-citation><mixed-citation xml:lang="en">Jung E.S., Kim S.W., Moon C.M., Shin D.J., Son N.H., Kim E.S. et al. Relationships between genetic polymorphisms of triggering receptor expressed on myeloid cells-1 and inflammatory bowel diseases in the Korean population. Life Sci. 2011;89(9–10):289–294. DOI: 10.1016/j.lfs.2011.06.018.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Saadipour K. TREM-1: A potential therapeutic target for alzheimer’s disease. Neurotox. Res. 2017;32(1):14–16. DOI: 10.1007/s12640-017-9716-y.</mixed-citation><mixed-citation xml:lang="en">Saadipour K. TREM-1: A potential therapeutic target for alzheimer’s disease. Neurotox. Res. 2017;32(1):14–16. DOI: 10.1007/s12640-017-9716-y.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Peng L.S., Li J., Zhou G.S., Deng L.H., Yao H.G. Relationships between genetic polymorphisms of triggering receptor expressed on myeloid cells-1 and septic shock in a Chinese Han population. World J. Emerg. Med. 2015;6(2):123–130. DOI: 10.5847/wjem.j.1920-8642.2015.02.007.</mixed-citation><mixed-citation xml:lang="en">Peng L.S., Li J., Zhou G.S., Deng L.H., Yao H.G. Relationships between genetic polymorphisms of triggering receptor expressed on myeloid cells-1 and septic shock in a Chinese Han population. World J. Emerg. Med. 2015;6(2):123–130. DOI: 10.5847/wjem.j.1920-8642.2015.02.007.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Chen Q., Zhou H., Wu S., Wang H., Lv C., Cheng B. et al. Lack of association between TREM-1 gene polymorphisms and severe sepsis in a Chinese Han population. Hum. Immunol. 2008;69(3):220–226. DOI: 10.1016/j.humimm.2008.01.013.</mixed-citation><mixed-citation xml:lang="en">Chen Q., Zhou H., Wu S., Wang H., Lv C., Cheng B. et al. Lack of association between TREM-1 gene polymorphisms and severe sepsis in a Chinese Han population. Hum. Immunol. 2008;69(3):220–226. DOI: 10.1016/j.humimm.2008.01.013.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Runzheimer J., Mewes C., Büttner B., Hinz J., Popov A.F., Ghadimi M. et al. Lack of an association between the functional polymorphism TREM-1 rs2234237 and the clinical course of sepsis among critically ill Caucasian patients – A monocentric prospective genetic association study. J. Clin. Med. 2019;8(3):301. DOI: 10.3390/jcm8030301.</mixed-citation><mixed-citation xml:lang="en">Runzheimer J., Mewes C., Büttner B., Hinz J., Popov A.F., Ghadimi M. et al. Lack of an association between the functional polymorphism TREM-1 rs2234237 and the clinical course of sepsis among critically ill Caucasian patients – A monocentric prospective genetic association study. J. Clin. Med. 2019;8(3):301. DOI: 10.3390/jcm8030301.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
